Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Alzheimer's disease (AD), like many other neurodegenerative ...

Class:IdSummation:8868373
_displayNameAlzheimer's disease (AD), like many other neurodegenerative ...
_timestamp2016-04-22 18:44:08
created[InstanceEdit:8868372] Orlic-Milacic, Marija, 2016-04-20
literatureReference[LiteratureReference:8868146] Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death
modified[InstanceEdit:8868387] Orlic-Milacic, Marija, 2016-04-20
[InstanceEdit:8868679] Orlic-Milacic, Marija, 2016-04-22
[InstanceEdit:8868681] Orlic-Milacic, Marija, 2016-04-22
textAlzheimer's disease (AD), like many other neurodegenerative diseases, is characterized by nuclear envelope fragmentation. Based on a mouse AD model, nuclear fragmentation is initiated by phosphorylation of nuclear lamins by p25-activated CDK5. The CDK5:p25 complex phosphorylates lamin B1 (LMNB1) at serine residues S23 and S393. Nuclear envelope fragmentation increases access of the CDK5:p25 complex to nuclear proteins and precedes neuronal death (Chang et al. 2011).
(summation)[Reaction:8868340] CDK5:p25 phosphorylates lamin B1 [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Alzheimer's disease (AD), like many other neurodegenerative ... (8868373)